Get Ready to Geek Out: Unity Biotechnology’s Latest Update on UBX1325 Clinical Trial for Diabetic Macular Edema!

Hey there fellow aging disease warriors! Exciting News Ahead! Mark your calendars for Tuesday, November 1 at 5:00 a.m. PT/8:00 a.m. ET for an exclusive update with retinal expert Arshad M. Khanani, M.D., M.A., FASRS! Get ready for some groundbreaking information on the Phase 2 Clinical Trial of UBX1325 in Patients with Diabetic Macular Edema,…

Read More

Breaking News: Oak Ridge Financial Services Inc. Reports Strong Third Quarter 2022 Results and Declares Quarterly Cash Dividend of $0.08 Per Share

Oak Ridge Financial Services, Inc. Announces Third Quarter 2022 Results and Quarterly Cash Dividend of $0.08 per share Embracing Growth and Success As Oak Ridge Financial Services, Inc. continues to thrive, the recent announcement of their third quarter 2022 results is a testament to their commitment to excellence. With a quarterly cash dividend of $0.08…

Read More

Clever, Personable, and Unconventional: Foundation for Opioid Response Efforts Launches Initiative to Support Schools in Accessing Medicaid Funding for Substance Misuse Prevention Programs

Foundation for Opioid Response Efforts Announces Initiative to Help Schools Access Medicaid Funding for Substance Misuse Prevention Programs New York, Oct. 31, 2022 (GLOBE NEWSWIRE) — Medicaid funding is available to expand school-based substance misuse prevention programs, however many school districts have limited access to the knowledge and technical assistance to obtain this funding. The…

Read More

FastWyre’s Fiber Optic Network Expansion: Bringing High-Speed Internet to 9 U.S. Communities!

Fastwyre’s New Expansion Plan Will Supply Fiber-Optic Network to Nine U.S. Communities Exciting News for Fastwyre Customers! Fastwyre Broadband, known for its commitment to providing top-notch internet services, has just announced a major expansion plan that will bring fiber-optic networks to nine communities across the United States. This move is part of the company’s strategic…

Read More

Reviva Pharmaceuticals Shares Exciting Update on Global Enrollment for Pivotal Phase 3 RECOVER Study: A Promising Step Towards Evaluating Brilaroxazine for Schizophrenia Treatment

Reviva Pharmaceuticals Announces Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia Enrollment ongoing at multiple sites in the US and Europe; site initiation in Asia expected in November 2022 Enrollment on pace, with over 30% enrolled in the United States Topline data for RECOVER evaluating brilaroxazine for schizophrenia expected in…

Read More

Set Sail for Success: Norwegian Cruise Line Holdings to Unveil Third Quarter 2022 Financial Results in Upcoming Conference Call!

Company Invites all NCLH Shareholders to Submit Questions for Management Ahead of Earnings Call MIAMI, Oct. 31, 2022 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings” or the “Company”) announced today it will report third quarter 2022 financial results on Tuesday, November 8, 2022…

Read More

From Chips to Riches: Vishay Intertechnology Snags Maxpower Semiconductor for $50 Million!

Welcome to the Silicon Valley of Vishay Intertechnology! Acquisition of SiC Technologies to Enhance Vishay’s MOSFET Product Offerings MALVERN, Pa., Oct. 31, 2022 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive electronic components, announced that on October 28, 2022, Vishay acquired MaxPower Semiconductor, Inc….

Read More